IRDI Gestion is a regional investment capital firm with a focus on fostering economic growth and job creation in the Southwest of France. With over 35 years of experience, they manage €150 million and offer financial support to SMEs in various stages of development, ranging from creation to transmission. Through a partnership approach, IRDI Gestion works closely with companies to provide equity ranging from €100,000 to €5,000,000. The group comprises three SCR entities: IRDI, MPcroissance, and IRDInov, each dedicated to supporting industrial growth, small businesses, and innovative startups, respectively. Approved by the AMF in 2015, IRDI Gestion is committed to structuring the group and driving new development projects to support the regional economy.
REEV is focused on enhancing the mobility of individuals with walking disorders by creating intelligent wearable robotics. These motorized orthosis devices are designed to be lightweight and personalized, providing intuitive support that helps users walk, stand, sit, and navigate stairs with confidence. By diminishing muscle fatigue and facilitating daily movements, REEV aims to improve the quality of life for its users, allowing them to regain autonomy and independence in their everyday activities. The company’s mission is rooted in the belief that everyone, regardless of their level of disability or age, deserves the opportunity to enjoy their mobility fully.
Starfish Bioscience
Seed Round in 2024
Starfish Bioscience specializes in developing microbiological solutions for agriculture and vineyards, aiming to regenerate soils by restoring their microbiomes. The company provides analysis of soil microbiomes and creates innovative solutions to enhance soil health and crop yields. By focusing on sustainability and productivity, Starfish Bioscience seeks to minimize environmental impact and address future challenges in global agriculture, ultimately contributing to the well-being of humanity and the preservation of the Earth.
Micropep
Series B in 2024
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.
REEV
Seed Round in 2023
REEV is focused on enhancing the mobility of individuals with walking disorders by creating intelligent wearable robotics. These motorized orthosis devices are designed to be lightweight and personalized, providing intuitive support that helps users walk, stand, sit, and navigate stairs with confidence. By diminishing muscle fatigue and facilitating daily movements, REEV aims to improve the quality of life for its users, allowing them to regain autonomy and independence in their everyday activities. The company’s mission is rooted in the belief that everyone, regardless of their level of disability or age, deserves the opportunity to enjoy their mobility fully.
Ascendance
Venture Round in 2023
Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsion system ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’.
Poclain Hydraulics
Private Equity Round in 2022
Poclain Hydraulics is an independent industrial company that specializes in the design, manufacture, and sale of hydrostatic transmission systems. Renowned for its expertise, the company operates across a wide range of diversified markets, including agriculture, construction, material handling, automotive, and environmental sectors. Poclain Hydraulics focuses on developing zero-emission machines that deliver diesel-like performance and extended battery life, integrating electric technology into its products. Additionally, the company enhances vehicle performance, energy efficiency, and safety through its advanced engines, hydraulic pumps, and motors. Committed to innovation, Poclain Hydraulics is accelerating its digitalization efforts to optimize product systems and meet the evolving demands of its customers.
Micropep
Series A in 2022
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.
Mon Chasseur Immo
Venture Round in 2022
Mon Chasseur Immo is a real estate agency based in Montpellier, France, with additional offices in Paris, Lyon, and Bordeaux. Founded in 2012 and rebranded in 2018, the agency specializes in facilitating the search and acquisition of residential properties, including apartments and houses, across various cities such as Paris, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Strasbourg, Toulouse, and Aix-en-Provence. The company provides a range of services, including targeted property visits, personalized support throughout the buying process, and assistance with real estate tax exemptions. Additionally, Mon Chasseur Immo offers a property search platform that allows users, including expatriates, to communicate directly with property owners, organize visits, and negotiate prices, streamlining the real estate transaction process.
Eldo
Venture Round in 2022
Eldo helps professionals and brands in the home improvement industry digitalize their communication and commercial management.
SeqOne Genomics
Series A in 2022
Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGS has had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
Neurinnov
Seed Round in 2021
Neurinnov specializes in the development and manufacturing of advanced neurostimulation solutions aimed at enhancing the quality of life for patients with spinal cord injuries. The company focuses on creating active implantable medical devices designed specifically for quadriplegic individuals, allowing them to regain essential hand grasping functions and increased autonomy. By employing sophisticated neurostimulation technology, Neurinnov's devices selectively activate specific muscle groups through targeted electrical stimulation of nerve fibers, thereby minimizing undesired side effects. This innovative approach offers a promising therapeutic avenue for individuals with paralysis, helping them restore vital motor functions.
Ascendance
Venture Round in 2021
Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsion system ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’.
Micropep
Series A in 2021
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.
Fineheart
Series B in 2021
Fineheart is a France-based medical device company that specializes in innovative technologies aimed at addressing cardiovascular diseases. The company is developing an implantable cardiac device that is wirelessly powered and fully implantable, designed to provide mechanical circulatory support. This novel device optimizes cardiac output while preserving the heart's natural contractility, thereby enabling patients with heart failure to restore normal cardiac function and improve their quality of life. Fineheart's focus on advanced medical solutions positions it as a key player in the evolving landscape of cardiovascular care.
SmartCatch
Venture Round in 2021
SmartCatch specializes in liquid biopsy technology aimed at enhancing cancer detection and treatment. The company has developed a minimally invasive method to extract circulating tumor cells, offering a series of products focused on the capture and isolation of these cells. This technology provides researchers and clinicians with valuable data that can significantly improve cancer patient outcomes. By empowering the medical community with advanced tools, SmartCatch contributes to the ongoing battle against cancer, facilitating better diagnostic and therapeutic approaches.
PeopleSpheres
Venture Round in 2021
PeopleSpheres is a Paris-based company that specializes in providing human resources management software solutions. Founded in 2010 and formerly known as NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. Recognizing a gap in the market for tailored HR management solutions, PeopleSpheres developed a customizable and scalable platform designed to meet the diverse needs of businesses. The company collaborates with leading national HR service providers to better serve American enterprises, ensuring that its offerings are both suitable and sustainable for a wide range of clients. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS.
Les Nouvelles Fermes
Seed Round in 2021
Les Nouvelles Fermes is a producer of fruits, vegetables, and meat, utilizing innovative aquaponics techniques to create a sustainable and efficient agricultural system. The company focuses on cultivating produce and fish in a closed-loop environment, ensuring that fruits, vegetables, and herbs are grown without the use of pesticides or antibiotics. By prioritizing local and responsible farming practices, Les Nouvelles Fermes aims to enhance the quality and taste of its products while promoting ultra-local agriculture. This approach not only supports sustainable farming but also fosters inclusivity by connecting market gardening with agro-industrial practices and startups. The company is dedicated to delivering ultra-fresh, well-bred produce that meets the growing demand for healthy and environmentally friendly food options.
AcuSurgical
Series A in 2021
AcuSurgical is a startup focused on advancing vitreo-retinal surgery through the development of a robotic surgical assistant. This innovative device is designed to enhance the precision and effectiveness of eye operations, particularly for treating retinal diseases like age-related macular degeneration. By providing surgeons with advanced tools to filter tremors and improve visualization during procedures, AcuSurgical aims to improve outcomes and increase the success rates of retinal surgeries.
Appvizer
Series A in 2020
Appvizer is a software comparison platform that assists businesses in selecting the most suitable BtoB applications from a comprehensive database covering over 506 categories, including CRM, payroll, and accounting software. The platform features more than 10,000 software packages, primarily focusing on Software as a Service (SaaS) solutions that are cloud-hosted and do not require installation. This model allows users to avoid maintenance, updates, and licensing issues, while benefiting from advanced collaborative features. In addition to software comparisons, Appvizer provides valuable resources such as articles and videos to address common professional challenges, and leverages machine learning technologies to enhance the user experience in finding the right software solutions.
EvidenceB
Venture Round in 2020
EvidenceB is a Paris-based company founded in 2017 that specializes in developing educational software designed to enhance school curriculums. The company creates learning platforms that integrate didactics, cognitive sciences, and artificial intelligence to provide tailored knowledge modules for students and supportive tools for teachers. Its adaptive intelligent tutoring system (ITS) addresses various learning challenges across K-12, higher education, and professional training by offering curriculum-agnostic designs and evidence-based gameplay. This software as a service (SaaS) model enables personalized learning experiences, facilitating deeper understanding of core concepts, even for lower-performing students. Additionally, EvidenceB's platform features tools for A/B testing and generates comprehensive learning analytics, allowing educators to monitor impact and effectiveness in real-time.
Blue Valet
Venture Round in 2018
Blue Valet is a French company founded in 2015, based in Mérignac, that specializes in online valet parking services for airports and train stations. The company offers a user-friendly platform that allows travelers to conveniently book valet parking, providing a stress-free and economical solution for both leisure and business customers. By catering to major mobility hubs, Blue Valet aims to enhance the travel experience, ensuring that clients can access their destinations without hassle.
Oncrawl
Venture Round in 2018
OnCrawl is a technical SEO platform that specializes in enterprise SEO audits and daily monitoring. Serving over a thousand clients across 66 countries, including notable companies such as Vistaprint, Canon, and Forbes, OnCrawl aims to enhance organic traffic, search rankings, and revenue by demystifying Google's algorithms. The platform provides search marketers with user-friendly dashboards and actionable reports, facilitating the entire SEO process. With a strong focus on data-driven insights, OnCrawl has garnered recognition in the industry, winning the Best SEO Tool award at the European Search Awards for three consecutive years and the Best Search Software Tool at the US Search Awards in 2019. The company has also successfully completed two funding campaigns to solidify its position as a leading SaaS provider in the SEO sector.
Vaonis
Seed Round in 2018
Vaonis SAS, founded in 2016 and based in Clapiers, France, specializes in the manufacture of innovative telescopes. The company's flagship product, Stellina, is a smart, portable telescope designed for ease of use. It can be connected to smartphones, allowing users to control the device remotely. Stellina features automated setup and guidance, making it particularly appealing to astrophotographers by facilitating faster and more efficient sky photography. Vaonis aims to enhance the accessibility and enjoyment of astronomy through its technologically advanced products.
BackBone
Angel Round in 2017
BackBone specializes in the creation, production and marketing of movement preservation solutions for the treatment of spinal pathologies which affects more than 40% of the world population.BackBone is supported by the best spine surgeons and professionals in the industry to launch its first implant (LISA) for lumbar pathologies.
Advicenne
Private Equity Round in 2017
Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.
Ixaltis
Venture Round in 2016
Ixaltis is a pharmaceutical company focused on developing therapeutics for genitourinary disorders that have unmet medical needs. Founded by a team of experts in urology and pharmaceuticals, the company aims to create innovative treatments by repurposing drugs that have already reached clinical stages for use in urogenital conditions. Ixaltis has established a proprietary position with Litoxetine, a drug leveraging its unique mechanism of action to address urogenital and other disorders. The company's goal is to enhance patient outcomes, particularly in improving urinary continence, through its novel pharmaceutical products.
Fineheart
Series A in 2016
Fineheart is a France-based medical device company that specializes in innovative technologies aimed at addressing cardiovascular diseases. The company is developing an implantable cardiac device that is wirelessly powered and fully implantable, designed to provide mechanical circulatory support. This novel device optimizes cardiac output while preserving the heart's natural contractility, thereby enabling patients with heart failure to restore normal cardiac function and improve their quality of life. Fineheart's focus on advanced medical solutions positions it as a key player in the evolving landscape of cardiovascular care.
Cacolac
Venture Round in 2015
Cacolac is a manufacturer specializing in food bars, chocolate drinks, and flavored milk. The company's flagship product is its chocolate milk drink, crafted by blending cocoa with fresh milk to deliver a distinctive taste at an affordable price. Cacolac focuses on providing quality beverages that appeal to a wide range of consumers, emphasizing both flavor and value in its offerings.
Groupe Ermic Developpement
Private Equity Round in 2014
Groupe Ermic Developpement has design and manufacture of microcomputer, electronic, electrical, and mechanical equipment.
LNC Therapeutics
Series B in 2012
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of € 16.5 million raised so far including € 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
ABIONYX Pharma
Series C in 2010
ABIONYX Pharma SA is a French biopharmaceutical company established in 2005, currently based in Labege. It specializes in the discovery and development of therapies targeting high-density lipoprotein (HDL) for treating cardiovascular and metabolic diseases. The company's primary focus is on developing HDL mimetics to rapidly regress atherosclerotic plaque in high-risk patients. Its lead product candidate, CER-001, is a Phase II clinical trial asset designed to mimic the properties of pre-beta HDL for treating post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients. Additionally, ABIONYX Pharma has another drug candidate, CER-209, in Phase I trials for metabolic diseases and liver-related conditions such as atherosclerosis and non-alcoholic steato-hepatitis.
AT Internet
Venture Round in 2009
AT Internet is one of the French Internet’s early pioneers. After two decades of existence, AT Internet is the only European company today among the worldwide leaders in digital analytics and digital intelligence. AT Internet’s Analytics Suite is used on more than 20,000 websites, mobile sites, and mobile apps globally. We count amongst our customers some of the world’s largest media groups (BBC, NPO, Schibsted, RTE, Le Monde…), banks (AXA, Société Générale, Crédit Agricole…) and have partnered with certain clients for more than a decade. Our unique approach to digital analytics is different from other solutions on the market. Having data you can trust is a mandatory foundation for any analytics project you undertake. That’s why our Analytics Suite features tools for easy quality control and dependable tagging for fully reliable data. Our solution and processes are completely compliant with stringent privacy laws (notably the European GDPR) and are certified by third-party auditors worldwide.
Neosens
Series B in 2009
Neosens SA specializes in the design and development of sensor solutions aimed at monitoring and controlling the quality of water and industrial liquids. The company offers advanced sensors that detect dissolved oxygen and systems for continuous fouling monitoring. Its technologies are applied across various sectors, including cooling systems, heat exchangers, potable and ultra-pure water management, as well as in industries such as food and beverage, pharmaceuticals, pulp and paper, and oil and gas. Founded in 2001 and headquartered in Labege, France, Neosens is committed to providing innovative solutions that enhance the efficiency and safety of liquid management in diverse environmental applications.
Leyio
Series A in 2009
Leyio is a French company founded in 2008, specializing in communicative electronic products that facilitate the exchange of digital data, such as photographs, videos, and documents, without the need for a computer. The company's offerings include personal sharing devices equipped with a fingerprint scanner for enhanced security, enabling users to carry and share various digital files, including music and work documents. Leyio has collaborated with notable clients like Sony, Toshiba, and 3COM, focusing on developing mobile solutions and PC-Card companions. The company is based in Gradignan, France, and aims to simplify the way consumers interact with and share their digital content.
Exakis
Series C in 2009
Exakis designs and develops software solutions for communications as well as Internet applications. The company’s products also assist in e-business, B2B, and intranet services. Exakis also provides consulting as well as software integration services. The company is based in Bidart, France with offices in Paris, Nantes, Lyon, and Bordeaux.
LDL Technology
Series B in 2008
LDL Technology is a privately owned company that specializes in the development, manufacture, and marketing of wireless embedded electronic systems. Founded in 2004 and headquartered in Toulouse, France, the company has operations in France, Japan, and the United States. LDL Technology's product offerings include tire pressure monitoring systems, vehicle immobilizer systems, keyless entry and start systems, and body control units. These products are utilized in a variety of vehicles, including motorcycles, buses, trucks, mass transit systems, inflatable boats, and subway systems. The company primarily serves the original equipment manufacturer market, delivering innovative solutions for the automotive industry.
Noomeo
Venture Round in 2008
Noomeo is an innovative company established in 2007, specializing in the development and marketing of 3D scanning tools and digital image processing solutions. The company focuses on providing user-friendly and ultra-portable systems that enable businesses to incorporate non-contact 3D digitization into their operations efficiently and cost-effectively. Through in-house research and development, as well as collaborations with research institutions, Noomeo continuously advances its technology offerings. The company has created OptiNum hardware solutions and NumiSoft software solutions, which facilitate the automatic creation of 3D mock-ups, positioning Noomeo as a leader in the 3D digitization sector.
Neosens
Venture Round in 2008
Neosens SA specializes in the design and development of sensor solutions aimed at monitoring and controlling the quality of water and industrial liquids. The company offers advanced sensors that detect dissolved oxygen and systems for continuous fouling monitoring. Its technologies are applied across various sectors, including cooling systems, heat exchangers, potable and ultra-pure water management, as well as in industries such as food and beverage, pharmaceuticals, pulp and paper, and oil and gas. Founded in 2001 and headquartered in Labege, France, Neosens is committed to providing innovative solutions that enhance the efficiency and safety of liquid management in diverse environmental applications.
Seanodes
Series B in 2007
Seanodes SA develops data storage domain and shared internal storage solutions in France. It offers Exanodes, a software solution, which creates a shared storage system using the cluster's own hard disks. The company’s technology virtualizes storage assets to leverage underused internal disks and direct attached storage into a virtual shared storage array. It also provides online support, implementation, and consulting services. The company serves small and medium businesses, service providers, high performance computing, government, life sciences, manufacturing, media and entertainment, and oil and gas sectors through a network of resellers internationally. Seanodes SA was founded in 2002 and is based in Boulogne Billancourt, France.
PraXcell
Venture Round in 2006
PraXcell is created in 2003. The company's principal activity is the development of advanced tools for cellular therapy. These are the human stem cells and the medical devices.
LDL Technology
Series A in 2005
LDL Technology is a privately owned company that specializes in the development, manufacture, and marketing of wireless embedded electronic systems. Founded in 2004 and headquartered in Toulouse, France, the company has operations in France, Japan, and the United States. LDL Technology's product offerings include tire pressure monitoring systems, vehicle immobilizer systems, keyless entry and start systems, and body control units. These products are utilized in a variety of vehicles, including motorcycles, buses, trucks, mass transit systems, inflatable boats, and subway systems. The company primarily serves the original equipment manufacturer market, delivering innovative solutions for the automotive industry.
Seanodes
Series A in 2004
Seanodes SA develops data storage domain and shared internal storage solutions in France. It offers Exanodes, a software solution, which creates a shared storage system using the cluster's own hard disks. The company’s technology virtualizes storage assets to leverage underused internal disks and direct attached storage into a virtual shared storage array. It also provides online support, implementation, and consulting services. The company serves small and medium businesses, service providers, high performance computing, government, life sciences, manufacturing, media and entertainment, and oil and gas sectors through a network of resellers internationally. Seanodes SA was founded in 2002 and is based in Boulogne Billancourt, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.